Generation Bio Q1 2025 Update: Assets vs. Liabilities
| Field | Detail |
|---|---|
| Company | Generation Bio Co. |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Gen Bio Q1: Assets $67M, Liabilities $67M. Uh oh.
AI Summary
Generation Bio Co. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $66,971,977 and total liabilities of $67,008,511 for the quarter. This filing provides an update on the company's financial position and operational activities.
Why It Matters
This filing reveals Generation Bio's financial standing as of Q1 2025, showing a slight deficit where liabilities exceed assets, which could impact future operations and investment.
Risk Assessment
Risk Level: medium — The company's liabilities slightly exceed its assets as of March 31, 2025, indicating potential financial strain.
Key Numbers
- $66.97M — Total Assets (As of March 31, 2025)
- $67.01M — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- Generation Bio Co. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- $66,971,977 (dollar_amount) — Total assets
- $67,008,511 (dollar_amount) — Total liabilities
FAQ
What were Generation Bio's total assets as of March 31, 2025?
Generation Bio's total assets were $66,971,977 as of March 31, 2025.
What were Generation Bio's total liabilities as of March 31, 2025?
Generation Bio's total liabilities were $67,008,511 as of March 31, 2025.
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the company's primary business sector?
The company operates in Pharmaceutical Preparations (SIC code 2834).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Generation Bio Co..